---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-21-003237"
form_type: "8-K"
ticker: "CMMB"
cik: "0001534248"
company_name: "Chemomab Therapeutics Ltd."
filed_at: "2021-10-25T23:59:59+00:00"
generated_at: "2026-06-28T18:26:47.290222+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Chemomab Therapeutics files updated corporate presentation for October 2021

## Summary
- Filed an updated corporate presentation covering its fibrotic disease pipeline.
- Presentation date is October 2021; no specific financial or clinical data disclosed in the filing.
- Presentation is furnished under Item 7.01 Regulation FD, not incorporated by reference.
- No material changes to previously disclosed information are evident from the filing.

## SEC filing metadata
- accession: 0001178913-21-003237
- form_type: 8-K
- ticker: CMMB
- cik: 0001534248
- company_name: Chemomab Therapeutics Ltd.
- filed_at: 2021-10-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534248/000117891321003237/0001178913-21-003237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534248/000117891321003237/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-21-003237
- JSON: https://secwatch.observer/filing/0001178913-21-003237.json
- Plain text: https://secwatch.observer/filing/0001178913-21-003237.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.